Europäischer Markt für medizinisches Cannabis – Branchentrends und Prognose bis 2031

Bericht anpassenBericht anpassen Jetzt kaufen Jetzt kaufen Kostenloser Beispielbericht Kostenloser Beispielbericht
Home Pharmaceutical Europe Medical Cannabis Market
Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Europäischer Markt für medizinisches Cannabis – Branchentrends und Prognose bis 2031

  • Pharmaceutical
  • Publish Reports
  • Jan 2024
  • Europe
  • 350 Seiten
  • Anzahl der Tabellen: 460
  • Anzahl der Abbildungen: 24
Jetzt kaufen Jetzt kaufen

Europe Medical Cannabis Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
 2024 –2031
Diagramm Marktgröße (Basisjahr)
 USD 2,625.67 million
Diagramm Marktgröße (Prognosejahr)
 USD 24,646.06 million
Diagramm CAGR
 %
Diagramm Wichtige Marktteilnehmer
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Anfrage zur Freischaltung

>Europäischer Markt für medizinisches Cannabis, nach Produkt (Öl, getrocknetes medizinisches Cannabis, medizinische Cannabiskapseln, ganze Blüten, gemahlene Blüten, Vape Pen, Cremes und Feuchtigkeitscremes und andere), Quelle (synthetisch und natürlich), Art (Cannabis Indica, Sativa und Hybrid), Derivate (Cannabidiol (CBD), Tetrahydrocannabinol (THC) /Delta-8-Tetrahydrocannabinol und andere), Anwendung (Schmerzbehandlung, Angstzustände, Muskelkrämpfe, Übelkeit, Appetitlosigkeit, Krebs, Arthritis, Alzheimer-Krankheit/Migräne, Epilepsie, Depressionen und Schlafstörungen, Multiple Sklerose, Autismus, psychische Erkrankungen, Stimmungsaufhellung und andere), Verabreichungsweg (orale Lösungen und Kapseln, Rauchen, Verdampfer, Topika und andere), Endverbraucher (Pharmaindustrie, Forschungs- und Entwicklungszentren, häusliche Pflege, Krankenhaus, Reha-Zentren und andere), Vertriebskanal (B2B und B2C) – Branchentrends und Prognose bis 2031.

Europäischer Markt für medizinisches Cannabis

Medizinisches Cannabis – Marktanalyse und Einblicke in Europa

Legales Cannabis ist eine der am schnellsten wachsenden Branchen in europäischen Staaten und hat große Auswirkungen auf die Lebensmittel- und Getränke-, Textil-, Chemie- und viele andere Branchen. Hanfsamen werden seit Tausenden von Jahren als Nahrungsmittel verwendet. Diese Samen enthalten sehr wenig THC (δ-9-Tetrahydrocannabinol) und unterscheiden sich daher von medizinischem Marihuana.

Europäischer Markt für medizinisches Cannabis

Europäischer Markt für medizinisches Cannabis

Laut einer Analyse von Data Bridge Market Research wird der Markt für medizinisches Cannabis im Prognosezeitraum von 2024 bis 2031 voraussichtlich mit einer durchschnittlichen jährlichen Wachstumsrate von 33,6 % wachsen und von 2.625,67 Millionen US-Dollar im Jahr 2023 auf 24.646,06 Millionen US-Dollar im Jahr 2031 ansteigen. 

Berichtsmetrik

Details

Prognosezeitraum

2024 bis 2031

Basisjahr

2023

Historische Jahre

2022 (anpassbar auf 2016–2021)

Quantitative Einheiten

Umsatz in Mio. USD

Abgedeckte Segmente

Produkt (Öl, getrocknetes medizinisches Cannabis, medizinische Cannabiskapseln, ganze Blüten, gemahlene Blüten, Vape Pen, Cremes und Feuchtigkeitscremes und andere), Quelle (synthetisch und natürlich), Art (Cannabis Indica, Sativa und Hybrid), Derivate ( Cannabidiol (CBD), Tetrahydrocannabinol (THC) / Delta-8-Tetrahydrocannabinol und andere), Anwendung (Schmerzbehandlung, Angstzustände, Muskelkrämpfe, Übelkeit, Appetitlosigkeit, Krebs, Arthritis , Alzheimer-Krankheit / Migräne, Epilepsie, Depressionen und Schlafstörungen, Multiple Sklerose, Autismus, psychische Erkrankungen, Stimmungsaufhellung und andere), Verabreichungsweg (orale Lösungen und Kapseln, Rauchen, Verdampfer, Topika und andere), Endbenutzer (Pharmaindustrie, Forschungs- und Entwicklungszentren, häusliche Pflege, Krankenhaus, Reha-Zentren, andere), Vertriebskanal (B2B und B2C)

Abgedeckte Länder

Deutschland, Frankreich, Großbritannien, Spanien, Italien, Türkei, Niederlande, Belgien, Schweiz, Griechenland, Luxemburg und Rest von Europa

Abgedeckte Marktteilnehmer

Tilray, Althea Company Pty Ltd (eine Tochtergesellschaft der Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY und Sanity Group GmbH unter anderem

Definition des europäischen Marktes für medizinisches Cannabis

Cannabis ist eine psychoaktive Droge, die aus der Cannabispflanze der Familie der Hanfgewächse gewonnen wird. Seit mehreren Jahren wird es medizinisch verwendet. Es hat ein breites Anwendungsspektrum bei der Behandlung verschiedener Krankheiten, darunter chronische Schmerzen, Krebs, Depressionen, Diabetes, Arthritis, Glaukom, Epilepsie, Migräne, AIDS und Alzheimer.

Dynamik des europäischen Marktes für medizinisches Cannabis

Treiber

  • Anstieg der geriatrischen Bevölkerung

Die wachsende geriatrische Bevölkerung auf der ganzen Welt ist anfälliger für chronische Krankheiten, die häufiger Arztbesuche erfordern. Die stetig alternde Bevölkerung leidet unter verschiedenen Gesundheitsproblemen, darunter Diabetes, Depressionen und Demenz. Medizinisches Cannabis hat die Eigenschaften, diese Krankheiten zu behandeln, und daher spielt die wachsende Bevölkerung eine wichtige Rolle.

  • Anstieg der Fälle von Krankheiten, die den Konsum von Cannabis erfordern

Chronische Krankheiten sind weltweit weit verbreitete Gesundheitsprobleme. Weltweit leidet jeder dritte Erwachsene an einer chronischen Krankheit. Neurologische Krankheiten beeinträchtigen die Gesundheit und Lebensqualität vieler Menschen. Chronische neurologische Krankheiten wie Alzheimer, Krebs, entzündliche Darmerkrankungen und Epilepsie können zu Krankenhausaufenthalten, langfristiger Behinderung, verminderter Lebensqualität und zum Tod führen.

Cannabis ist ein allgemeiner Begriff, der für die verschiedenen psychoaktiven Präparate der Pflanze Cannabis sativa verwendet wird. Cannabis wird zu medizinischen oder Freizeitzwecken verwendet. Da Cannabinoide mit Rezeptoren im Nervensystem reagieren, glauben Forscher, dass Cannabinoide bei der Behandlung anderer neurologischer Erkrankungen hilfreich sein könnten. Medizinisches Cannabis ist sicher und wirksam bei der Linderung von Symptomen wie Schmerzen, Schlafstörungen und Angstzuständen aufgrund chronischer Krankheiten bei älteren Erwachsenen.

Europäischer Markt für medizinisches Cannabis

Gelegenheiten

  • Strategische Initiativen von Marktteilnehmern

Der Bedarf an Medikamenten zur Behandlung von Kniebeschwerden ist in Europa aufgrund der zunehmenden Prävalenz und Inzidenz chronischer Kniebeschwerden, fortschrittlicher Therapien für Kniearthrose und Meniskusverletzungen sowie ungedeckter medizinischer Bedürfnisse gestiegen. Diese Faktoren (wie die zunehmende Inzidenz, die Zahl chronischer Kniebeschwerden und die Verfügbarkeit fortschrittlicher Therapien) erhöhen die Notwendigkeit orthopädischer Rehabilitationstherapien, und um die Marktnachfrage zu erfüllen, nutzen kleinere und größere Marktteilnehmer verschiedene Strategien.

  • Entwicklung neuartiger Produkte mit zunehmenden Forschungs- und Entwicklungsaktivitäten (F&E)

Das starke Wachstum der Nachfrage nach Cannabis mit der Legalisierung hat die Notwendigkeit erhöht, bessere Produktsorten und Liefersysteme zu entwickeln. Dies hat viele Unternehmen dazu veranlasst, Forschungs- und Entwicklungsaktivitäten durchzuführen, um die genetischen Verbesserungsstrategien für Cannabis zu prüfen.

Die Unternehmen konzentrieren sich stark auf die Entwicklung ertragreicher Sorten, verbesserter Herbizidtoleranz, niedrigerem THC-Gehalt und besserer Ernte- und Marktqualitäten von Cannabispflanzen. Durch die Verbesserung der Sorten wird die Produktion von Cannabis höherer Qualität ermöglicht, was wiederum die Nachfrage nach qualitativ hochwertigem Saatgut erhöht. Daher wird erwartet, dass die Entwicklung neuer Produkte eine Chance für den Markt darstellt.

Einschränkungen/Herausforderungen

• Langfristige und kurzfristige Nebenwirkungen im Zusammenhang mit dem Konsum von Cannabis und Cannabis-Überkonsum

Orthopädische Spezialisten beachten bestimmte Risiken bei der Verwendung der Implantate und der Einnahme der Medikamente. Bei Knieersatzoperationen treten Komplikationen auf, die durch die Operation oder ein fehlerhaftes Implantat entstehen. Das Lösen des Implantats ist eine der schwerwiegendsten Komplikationen nach einer Knieoperation, und Schmerzen sind die häufigste. Das Lösen kann Knochenbrüche, Instabilität und schwere Stürze verursachen. Fast alle schwerwiegenden Komplikationen erfordern eine Revisionsoperation. Die Risiken sind mechanische Risiken, das Lösen des Knieimplantats und körperliche Schmerzen.

Marihuana ist nach Alkohol die am zweithäufigsten konsumierte Psychodroge. Das Rauchen von THC-reichen Harzen, die aus der Cannabispflanze gewonnen werden, nimmt zu und hat bei den Konsumenten zu schweren Notsituationen geführt.

  • Fachkräftemangel

Die Cannabisindustrie ist nicht nur mit Lieferengpässen, Produktbeschränkungen und strengen Vorschriften konfrontiert, sondern auch mit dem Mangel an qualifiziertem Personal, das für einen reibungslosen Betrieb der Branche erforderlich ist. Die Cannabisindustrie hat mit aufkommenden Kandidatenproblemen und dem Mangel an qualifiziertem Personal zu kämpfen. Vom Stigma der Arbeit mit zuvor verbotenen Substanzen bis hin zu Fachwissen und Sicherheit ist die Branche mit all diesen Herausforderungen konfrontiert.

Jüngste Entwicklung

  • Im Mai 2020 gab Tilray bekannt, dass es die GMP-Zertifizierung nach den Standards der Europäischen Union erhalten habe, die es der Anlage ermöglicht, medizinische Cannabisextrakte im eigenen Haus herzustellen und fertige medizinische Cannabisprodukte zu exportieren. Dies half dem Unternehmen, sein Geschäft auszubauen
  • Im Februar 2022 schloss die Sanity Group GmbH, ein Geschäftsbereich von Sanity Medical, eine Vereinbarung mit der Telemedizinplattform Telaleaf, um die Telemedizin in der Cannabistherapie in Deutschland zu stärken

Umfang des europäischen Marktes für medizinisches Cannabis

Der europäische Markt für medizinisches Cannabis ist segmentiert nach Produkt, Quelle, Art, Derivaten, Anwendung, Verabreichungsweg, Endverbraucher und Vertriebskanal. Das Wachstum dieser Segmente hilft Ihnen bei der Analyse schwacher Wachstumssegmente in den Branchen und bietet den Benutzern einen wertvollen Marktüberblick und Markteinblicke, die ihnen bei der strategischen Entscheidungsfindung zur Identifizierung der wichtigsten Marktanwendungen helfen.

Produkt

  • Öl
  •  Getrocknetes medizinisches Cannabis
  •  Medizinische Cannabiskapseln
  •  Vape-Stift
  •  Ganze Blüte
  •  Cremes & Feuchtigkeitscremes
  •  Bodenblume
  •  Sonstiges

Auf der Grundlage des Produkts ist der Markt in Öl, medizinische Cannabiskapseln, ganze Blüten, gemahlene Blüten, Vape-Pen, getrocknetes medizinisches Cannabis, Cremes und Feuchtigkeitscremes und Sonstiges segmentiert.

Quelle

  • Natürlich
  • Synthetik

Auf Grundlage der Quelle wird der Markt in synthetische und natürliche Produkte segmentiert.

Spezies

  • Sativa
  • Hybrid
  • Cannabis Indica

Auf der Grundlage der Arten ist der Markt in Sativa, Hybrid und Cannabis Indica segmentiert.

Derivate

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
  • Sonstiges

Auf der Grundlage von Derivaten ist der Markt in Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol und andere segmentiert.

Anwendung

  • Schmerztherapie
  • Angst
  •  Muskelkrämpfe
  •  Brechreiz
  •  Appetitlosigkeit
  •  Krebs
  •  Arthritis
  •  Alzheimer-Krankheit/Migräne
  •  Epilepsie
  •  Depressionen und Schlafstörungen
  •  Multiple Sklerose
  •  Autismus
  •  Psychische Erkrankungen
  •  Elevate-Mod
  •  Sonstiges

Auf der Grundlage der Anwendung ist der Markt in Schmerzbehandlung, Angstzustände, Muskelkrämpfe, Übelkeit, Appetitlosigkeit, Krebs, Arthritis, Alzheimer-Krankheit/Migräne, Epilepsie, Depression und Schlafstörungen, Multiple Sklerose, Autismus, psychische Erkrankungen, Elevate Modd und andere unterteilt.

Verabreichungsweg

  • Lösung zum Einnehmen und Kapseln
  • Rauchen
  • Themen
  • Verdampfer
  • Sonstiges

Auf der Grundlage der Verabreichungsart ist der Markt in orale Lösungen und Kapseln, Rauchmittel , topische Mittel, Verdampfer und Sonstiges segmentiert.

Endbenutzer

  • Häusliche Pflege
  • Krankenhaus
  • Reha-Zentren
  • Pharmazeutische Industrie
  • Forschungs- und Entwicklungszentren
  • Sonstiges

Auf der Grundlage des Endbenutzers ist der Markt in häusliche Pflege, Krankenhäuser, Reha-Zentren, Pharmaindustrie, Forschungs- und Entwicklungszentren und andere segmentiert.

Vertriebskanal

  • B2C
  • B2B

Auf der Grundlage des Vertriebskanals ist der Markt in B2C und B2B segmentiert.

Europäischer Markt für medizinisches Cannabis

Europäischer Markt für medizinisches Cannabis: Regionale Analyse/Einblicke

Der europäische Markt für medizinisches Cannabis ist nach Produkt, Quelle, Art, Derivaten, Anwendung, Verabreichungsweg, Endverbraucher und Vertriebskanal segmentiert.

Die im europäischen Marktbericht für medizinisches Cannabis abgedeckten Länder sind Deutschland, Frankreich, Großbritannien, Spanien, Italien, Türkei, Niederlande, Belgien, Schweiz, Griechenland, Luxemburg und der Rest von Europa.

Aufgrund der Zunahme von Kniearthrose und Knieendoprothesen sowie der Vielzahl orthopädischer Zentren in Deutschland wird Deutschland voraussichtlich den Markt dominieren.

Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierungen auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, Länderdemografie, Krankheitsepidemiologie und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit regionaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.

Wettbewerbsumfeld und Marktanteilsanalyse: Europäischer Markt für medizinisches Cannabis

Die Wettbewerbslandschaft des europäischen Marktes für medizinisches Cannabis liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang, Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen in Bezug auf den europäischen Markt für medizinisches Cannabis.

Zu den wichtigsten Akteuren auf dem europäischen Markt für medizinisches Cannabis zählen unter anderem Tilray, Althea Company Pty Ltd (eine Tochtergesellschaft der Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY und Sanity Group GmbH.

SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Sample Image Klicken Sie auf das Bild, um es zu vergrößern
  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Inhaltsverzeichnis

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe MEDICAL CANNABIS market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. EUROPE MEDICAL CANNABIS MARKET: REGULATIONS
    1. UNITED STATES
    2. CANADA
    3. AUSTRALIA
    4. THAILAND
  6. EUROPE MEDICAL CANNABIS MARKET: SUPPLY CHAIN ANALYSIS
    1. CULTIVATORS AND GROWERS
    2. MANUFACTURER AND PRODUCER
    3. TESTERS
    4. WHOLESALE AND DISTRIBUTORS
    5. RETAILERS
  7. Market Overview
    1. DRIVERS
      1. INCREASED MEDICINAL USE
      2. LEGALIZATION OF CANNABIS
      3. INITIATIVES TAKEN BY MANUFACTURERS
      4. INCREASED USAGE OF CANNABIS SEEDS IN COSMETIC PRODUCTS
      5. FUNCTIONAL PROPERTIES OF CANNABIS AND THEIR INCREASED USE IN DIFFERENT INDUSTRIES
    2. RESTRAINTS
      1. COMPLEX REGULATORY STRUCTURE FOR USAGE OF CANNABIS
      2. LONG TERM USE CAN CAUSE ADVERSE EFFECTS
      3. HIGH COST
    3. OPPORTUNITIES
      1. NOVEL PRODUCT DEVELOPMENT WITH INCREASING R & D ACTIVITIES
      2. INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSE
      3. GROWING GERIATRIC POPULATION
      4. INCREASING PREVALENCE OF CHRONIC DISEASES
    4. CHALLENGES
      1. RISE OF MARIJUANA BLACK MARKET
      2. SIDE EFFECTS RELATED TO THE USE OF CANNABIS
      3. SHORTAGE OF PERSONNEL
  8. IMPACT OF COVID-19 ON EUROPE MEDICAL CANNABIS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
    5. CONCLUSION:
  9. EUROPE MEDICAL CANNABIS MARKET, BY product
    1. overview
    2. oil
      1. By Type
        1. CBD Oil Concentrates
        2. CBD Vape Oil
        3. CBD Tinctures
      2. By Source
        1. Marijuana Based
        2. Hemp Based
      3. By Species
        1. Sativa
        2. Hybrid
        3. Cannabis Indica
    3. Dried Medical cannabis
      1. Cannabis Indica
      2. Sativa
      3. Hybrid
    4. medical cannabis capsules
      1. By Type
        1. Oil Based Cannabis Capsules
        2. Power Based Cannabis Capsules
        3. Others
      2. By Concentrates
        1. High CBD Capsules Digital
        2. High THC Capsule
        3. THC/CBD balanced capsule
        4. CBD Isolate Capsule
        5. By Species
        6. Sativa
        7. Hybrid
        8. Cannabis Indica
    5. vape pen
      1. Cannabis Indica
      2. Sativa
      3. Hybrid
    6. whole flower
      1. Sativa
      2. Hybrid
      3. Cannabis Indica
    7. CREAMS & MOISTURIZER
    8. Ground Flower
      1. Sativa
      2. Cannabis Indica
      3. Hybrid
    9. patch
    10. mask & serum
    11. cleanser
    12. others
  10. EUROPE MEDICAL CANNABIS MARKET, BY application
    1. overview
    2. pain management
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Patch
      5. Ground Flower
      6. Creams & Moisturizer
      7. Vape Pen
      8. Whole Flower
      9. Masks & Serum
      10. Cleanser
      11. Others
    3. anxiety
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Ground Flower
      5. Vape Pen
      6. Whole Flower
      7. Others
    4. muscle spasms
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Patch
      5. Creams & Moisturizer
      6. Ground Flower
      7. Vape Pen
      8. Whole Flower
      9. Masks & Serum
      10. Cleanser
      11. Others
    5. nausea
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Ground Flower
      5. Creams & Moisturizer
      6. Patch
      7. Vape Pen
      8. Whole Flower
      9. Masks & Serum
      10. Cleanser
      11. Others
    6. appetite loss
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Ground Flower
      5. Whole Flower
      6. Vape Pen
      7. Patch
      8. Others
    7. cancer
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Patch
      5. Ground Flower
      6. Vape Pen
      7. Whole Flower
      8. Others
    8. arthritis
      1. Oil
      2. Medical cannabis and capsules
      3. Dried Medical Cannabis
      4. Patch
      5. Ground Flower
      6. Creams & Moisturizer
      7. Masks & Serum
      8. Whole Flower
      9. Vape Pen
      10. Cleanser
      11. Others
    9. alzheimer’s disease/Migranes
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Patch
      5. Ground Flower
      6. Vape Pen
      7. Whole Flower
      8. Others
    10. epilepsy
      1. Oil
      2. Medical cannabis and capsules
      3. Others
    11. depression and sleep disorders
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Patch
      5. Creams & Moisturizer
      6. Others
    12. multiple sclerosis
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Patch
      5. Ground Flower
      6. Vape Pen
      7. Whole Flower
      8. Others
    13. autism
      1. Oil
      2. Medical cannabis and capsules
      3. Others
    14. mental health conditions
      1. Oil
      2. Medical cannabis and capsules
      3. Others
    15. elevate Mood
      1. Oil
      2. Dried Medical Cannabis
      3. Medical cannabis and capsules
      4. Patch
      5. Creams & Moisturizer
      6. Masks & Serum
      7. Cleanser
      8. Others
    16. others
  11. EUROPE MEDICAL CANNABIS MARKET, BY derivatives
    1. overview
    2. CANNABIDIOL (CBD)
      1. Oil
      2. Medical Cannabis Capsules
      3. Ground Flower
      4. Patch
      5. Creams & Moisturizer
      6. Vape Pen
      7. Whole Flower
      8. Masks & Serum
      9. Cleanser
      10. Others
    3. tetrahydrocannabinol (thc)/Delta-8-TETRAHYDROCANNABINOL
      1. Oil
      2. Medical Cannabis Capsules
      3. Dried Medical Cannabis
      4. Ground Flower
    4. Patch
      1. Creams & Moisturizer
      2. Whole Flower
      3. Vape Pen
      4. Masks & Serum
      5. Cleanser
      6. Others
    5. CANNABIGEROL (CBG)
      1. Oil
      2. Whole Flower
      3. Medical cannabis and capsules
      4. Cleanser
    6. cannabinol (CBN)
    7. others
  12. EUROPE MEDICAL CANNABIS MARKET, BY source
    1. overview
    2. natural
    3. synthetic
  13. EUROPE MEDICAL CANNABIS MARKET, BY species
    1. overview
    2. sativa
    3. hybrid
    4. cannabis indica
  14. EUROPE MEDICAL CANNABIS MARKET, BY route of administration
    1. overview
    2. oral solutions and capsules
    3. smoking
    4. topicals
    5. vaporizers
    6. others
  15. EUROPE MEDICAL CANNABIS MARKET, BY end user
    1. overview
    2. homecare setting
    3. hospital
    4. rehab centers
    5. PHARMACEUTICAL INDUSTRY
    6. research and development centers
    7. others
  16. EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL
    1. overview
    2. B2C
      1. Pharmacies
      2. Conventional Stores
      3. Online Stores
      4. Others
    3. B2B
  17. Europe medical cannabis MARKET by geography
    1. europe
      1. germany
      2. italy
      3. u.k.
      4. NETHERLANDS
      5. switzerland
      6. france
      7. russia
      8. spain
      9. belgium
      10. rest of europe
  18. Europe Medical Cannabis market: COMPANY landscape
    1. company share analysis: Europe
  19. Swot analysis
  20. company profile
    1. MEDIPHARM LABS INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. APHRIA INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. tilray
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. Zenabis Europe Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. AURORA CANNABIS
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. gw pharmaceuticals plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Althea Company Pty Ltd (A subsidiary of Althea Group)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. Apothecanna
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. bARNEY’S FARM
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Bioactive solutions, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. bol pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. CANNABIS SEEDS USA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. canopy growth corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. Cresco Labs
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. Crop King Seeds
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. discover health llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. EcoGen Biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Elixinol Europe limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. endoca
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    20. EXTRACTAS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    21. FOLIUM BIOSCIENCES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    22. GREENWICH BIOSCIENCES, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    23. HARMONY
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    24. HUMBOLDT SEED COMPANY
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    25. IDT AUSTRALIA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    26. kiehl’s (a subsidiary of L'Oréal)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    27. mary’s nutritionals, LLC
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    28. medical marijuana, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    29. MEDIFARM
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    30. pacific roots
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    31. pharmahemp
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    32. pure ratios
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    33. PEACE NATURALS PROJECT INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    34. seed Cellar
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    35. SEEDS FOR ME
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    36. THC EUROPE GROUP LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    37. upstate elevator supply co.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    38. vermont hemp health
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  21. questionnaire
  22. related reports

Tabellenverzeichnis

TABLE 1 Annual Cost of Cultivation:

TABLE 2 Annual Cost of Manufacturing:

TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED

TABLE 26 Europe MEDICAL CANNABIS market, By application, 2019-2028 (USD million)

TABLE 27 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 28 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 29 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by anxiety, By Region, 2021-2028 (USD Million)

TABLE 30 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 31 EUROPE muscle spasms IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 32 Europe muscle spasms in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 33 EUROPE nausea IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 34 Europe nausea in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 35 EUROPE appetite loss IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 36 Europe appetite loss in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 37 EUROPE cancer IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 38 Europe cancer in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 39 EUROPE arthritis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 40 Europe arthritis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 41 EUROPE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 42 Europe ALZHEIMER’S DISEASE/MIGRANES in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 43 EUROPE epilepsy IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 44 Europe epilepsy in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 45 EUROPE depression and sleep disorders IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 46 Europe depression and sleep disorders in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 47 EUROPE multiple sclerosis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 48 Europe multiple sclerosis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 49 EUROPE autism IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 50 Europe autism in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 51 EUROPE mental health conditions IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 52 Europe mental health conditions in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 53 EUROPE elevate mood IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 54 Europe elevate mood in Medical Cannabis Market , By Application, 2019-2028 (USD Million)

TABLE 55 EUROPE others IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)

TABLE 65 Europe medical cannabis Market, BY source, 2019-2028 (USD MILLION)

TABLE 66 Europe natural in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 67 Europe synthetic in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 68 Europe medical cannabis Market, By Species, 2019-2028 (USD Million)

TABLE 69 Europe sativa in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 70 Europe hybrid in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 71 Europe cannabis indica in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 72 Europe medical cannabis Market, By route of administration, 2019-2028 (USD Million)

TABLE 73 Europe oral solutions and capsules in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 74 Europe smoking in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 75 Europe topicals in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 76 Europe vaporizers in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 77 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 78 Europe medical cannabis Market, BY end user, 2019-2028 (USD MILLION)

TABLE 79 Europe homecare setting in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 80 Europe hospital in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 81 Europe rehab centers in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 82 Europe pharmaceutical industry in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 83 Europe research and development centers in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 84 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 85 Europe medical cannabis Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)

TABLE 86 Europe b2c in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 87 Europe b2C in medical cannabis Market, By distribution channel, 2019-2028 (USD Million)

TABLE 88 Europe b2b in medical cannabis Market, By Region, 2019-2028 (USD Million)

TABLE 89 europe medical cannabis Market, By COUNTRY, 2021-2028 (USD million)

TABLE 90 EUROPE medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 91 EUROPE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 92 EUROPE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 93 EUROPE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 94 EUROPE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 95 EUROPE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 96 EUROPE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 97 EUROPE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 98 EUROPE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 99 EUROPE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 100 EUROPE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 101 EUROPE medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 102 EUROPE medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 103 EUROPE medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 104 EUROPE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 105 EUROPE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 106 EUROPE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 107 EUROPE medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 108 EUROPE pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 109 EUROPE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 110 EUROPE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 111 EUROPE nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 112 EUROPE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 113 EUROPE cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 114 EUROPE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 115 EUROPE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 116 EUROPE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 117 EUROPE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 118 EUROPE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 119 EUROPE autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 120 EUROPE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 121 EUROPE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 122 EUROPE medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 123 EUROPE medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 124 EUROPE medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 125 EUROPE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 126 GERMANY medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 127 GERMANY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 128 GERMANY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 129 GERMANY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 130 GERMANY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 131 GERMANY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 132 GERMANY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 133 GERMANY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 134 GERMANY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 135 GERMANY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 136 GERMANY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 137 GERMANY medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 138 GERMANY medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 139 GERMANY medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 140 GERMANY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 141 GERMANY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 142 GERMANY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 143 GERMANY medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 144 GERMANY pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 145 GERMANY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 146 GERMANY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 147 GERMANY nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 148 GERMANY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 149 GERMANY cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 150 GERMANY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 151 GERMANY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 152 GERMANY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 153 GERMANY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 154 GERMANY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 155 GERMANY autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 156 GERMANY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 157 GERMANY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 158 GERMANY medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 159 GERMANY medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 160 GERMANY medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 161 GERMANY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 162 ITALY medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 163 ITALY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 164 ITALY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 165 ITALY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 166 ITALY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 167 ITALY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 168 ITALY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 169 ITALY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 170 ITALY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 171 ITALY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 172 ITALY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 173 ITALY medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 174 ITALY medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 175 ITALY medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 176 ITALY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 177 ITALY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 178 ITALY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 179 ITALY medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 180 ITALY pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 181 ITALY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 182 ITALY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 183 ITALY nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 184 ITALY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 185 ITALY cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 186 ITALY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 187 ITALY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 188 ITALY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 189 ITALY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 190 ITALY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 191 ITALY autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 192 ITALY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 193 ITALY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 194 ITALY medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 195 ITALY medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 196 ITALY medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 197 ITALY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 198 U.K. medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 199 U.K. type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 200 U.K. source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 201 U.K. species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 202 U.K. dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 203 U.K. type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 204 U.K. concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 205 U.K. species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 206 U.K. vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 207 U.K. whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 208 U.K. ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 209 U.K. medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 210 U.K. medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 211 U.K. medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 212 U.K. cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 213 U.K. tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 214 U.K. cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 215 U.K. medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 216 U.K. pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 217 U.K. anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 218 U.K. muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 219 U.K. nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 220 U.K. appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 221 U.K. cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 222 U.K. arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 223 U.K. alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 224 U.K. epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 225 U.K. depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 226 U.K. multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 227 U.K. autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 228 U.K. mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 229 U.K. elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 230 U.K. medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 231 U.K. medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 232 U.K. medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 233 U.K. B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 234 NETHERLANDS medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 235 NETHERLANDS type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 236 NETHERLANDS source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 237 NETHERLANDS species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 238 NETHERLANDS dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 239 NETHERLANDS type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 240 NETHERLANDS concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 241 NETHERLANDS species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 242 NETHERLANDS vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 243 NETHERLANDS whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 244 NETHERLANDS ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 245 NETHERLANDS medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 246 NETHERLANDS medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 247 NETHERLANDS medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 248 NETHERLANDS cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 249 NETHERLANDS tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 250 NETHERLANDS cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 251 NETHERLANDS medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 252 NETHERLANDS pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 253 NETHERLANDS anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 254 NETHERLANDS muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 255 NETHERLANDS nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 256 NETHERLANDS appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 257 NETHERLANDS cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 258 NETHERLANDS arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 259 NETHERLANDS alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 260 NETHERLANDS epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 261 NETHERLANDS depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 262 NETHERLANDS multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 263 NETHERLANDS autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 264 NETHERLANDS mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 265 NETHERLANDS elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 266 NETHERLANDS medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 267 NETHERLANDS medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 268 NETHERLANDS medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 269 NETHERLANDS B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 270 SWITZERLAND medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 271 SWITZERLAND type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 272 SWITZERLAND source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 273 SWITZERLAND species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 274 SWITZERLAND dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 275 SWITZERLAND type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 276 SWITZERLAND concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 277 SWITZERLAND species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 278 SWITZERLAND vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 279 SWITZERLAND whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 280 SWITZERLAND ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 281 SWITZERLAND medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 282 SWITZERLAND medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 283 SWITZERLAND medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 284 SWITZERLAND cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 285 SWITZERLAND tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 286 SWITZERLAND cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 287 SWITZERLAND medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 288 SWITZERLAND pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 289 SWITZERLAND anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 290 SWITZERLAND muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 291 SWITZERLAND nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 292 SWITZERLAND appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 293 SWITZERLAND cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 294 SWITZERLAND arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 295 SWITZERLAND alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 296 SWITZERLAND epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 297 SWITZERLAND depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 298 SWITZERLAND multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 299 SWITZERLAND autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 300 SWITZERLAND mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 301 SWITZERLAND elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 302 SWITZERLAND medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 303 SWITZERLAND medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 304 SWITZERLAND medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 305 SWITZERLAND B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 306 FRANCE medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 307 FRANCE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 308 FRANCE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 309 FRANCE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 310 FRANCE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 311 FRANCE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 312 FRANCE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 313 FRANCE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 314 FRANCE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 315 FRANCE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 316 FRANCE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 317 FRANCE medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 318 FRANCE medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 319 FRANCE medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 320 FRANCE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 321 FRANCE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 322 FRANCE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 323 FRANCE medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 324 FRANCE pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 325 FRANCE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 326 FRANCE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 327 FRANCE nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 328 FRANCE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 329 FRANCE cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 330 FRANCE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 331 FRANCE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 332 FRANCE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 333 FRANCE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 334 FRANCE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 335 FRANCE autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 336 FRANCE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 337 FRANCE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 338 FRANCE medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 339 FRANCE medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 340 FRANCE medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 341 FRANCE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 342 RUSSIA medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 343 RUSSIA type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 344 RUSSIA source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 345 RUSSIA species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 346 RUSSIA dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 347 RUSSIA type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 348 RUSSIA concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 349 RUSSIA species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 350 RUSSIA vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 351 RUSSIA whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 352 RUSSIA ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 353 RUSSIA medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 354 RUSSIA medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 355 RUSSIA medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 356 RUSSIA cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 357 RUSSIA tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 358 RUSSIA cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 359 RUSSIA medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 360 RUSSIA pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 361 RUSSIA anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 362 RUSSIA muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 363 RUSSIA nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 364 RUSSIA appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 365 RUSSIA cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 366 RUSSIA arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 367 RUSSIA alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 368 RUSSIA epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 369 RUSSIA depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 370 RUSSIA multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 371 RUSSIA autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 372 RUSSIA mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 373 RUSSIA elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 374 RUSSIA medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 375 RUSSIA medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 376 RUSSIA medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 377 RUSSIA B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 378 SPAIN medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 379 SPAIN type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 380 SPAIN source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 381 SPAIN species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 382 SPAIN dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 383 SPAIN type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 384 SPAIN concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 385 SPAIN species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 386 SPAIN vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 387 SPAIN whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 388 SPAIN ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 389 SPAIN medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 390 SPAIN medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 391 SPAIN medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 392 SPAIN cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 393 SPAIN tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 394 SPAIN cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 395 SPAIN medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 396 SPAIN pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 397 SPAIN anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 398 SPAIN muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 399 SPAIN nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 400 SPAIN appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 401 SPAIN cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 402 SPAIN arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 403 SPAIN alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 404 SPAIN epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 405 SPAIN depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 406 SPAIN multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 407 SPAIN autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 408 SPAIN mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 409 SPAIN elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 410 SPAIN medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 411 SPAIN medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 412 SPAIN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 413 SPAIN B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 414 BELGIUM medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 415 BELGIUM type in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 416 BELGIUM source in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 417 BELGIUM species in oil in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 418 BELGIUM dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 419 BELGIUM type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 420 BELGIUM concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 421 BELGIUM species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 422 BELGIUM vape pen in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 423 BELGIUM whole flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 424 BELGIUM ground flower in medical cannabis Market, By product, 2021-2028 (USD million)

TABLE 425 BELGIUM medical cannabis Market, By source, 2021-2028 (USD million)

TABLE 426 BELGIUM medical cannabis Market, By species, 2021-2028 (USD million)

TABLE 427 BELGIUM medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 428 BELGIUM cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 429 BELGIUM tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 430 BELGIUM cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)

TABLE 431 BELGIUM medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 432 BELGIUM pain management in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 433 BELGIUM anxiety in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 434 BELGIUM muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 435 BELGIUM nausea in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 436 BELGIUM appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 437 BELGIUM cancer in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 438 BELGIUM arthritis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 439 BELGIUM alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 440 BELGIUM epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 441 BELGIUM depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 442 BELGIUM multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 443 BELGIUM autism in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 444 BELGIUM mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 445 BELGIUM elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)

TABLE 446 BELGIUM medical cannabis Market, By route of administration, 2021-2028 (USD million)

TABLE 447 BELGIUM medical cannabis Market, By end user, 2021-2028 (USD million)

TABLE 448 BELGIUM medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 449 BELGIUM B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)

TABLE 450 rest of europe medical cannabis Market, By product, 2021-2028 (USD million)

Abbildungsverzeichnis

FIGURE 1 Europe medical cannabis market: segmentation

FIGURE 2 Europe medical cannabis market: data triangulation

FIGURE 3 Europe medical cannabis market: DROC ANALYSIS

FIGURE 4 Europe medical cannabis market : Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 Europe medical cannabis market : COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe medical cannabis market: INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe medical cannabis market: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE medical cannabis MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 Europe medical cannabis market: vendor share analysis

FIGURE 10 Europe medical cannabis market: SEGMENTATION

FIGURE 11 increasing medicinal use and legalization of medical cannabis are expected to drive THE Europe medical cannabis market IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 oil segment is expected to account for the largest share of the Europe medical cananbis market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MEDICAL CANNABIS MARKET

FIGURE 14 Europe MEDICAL CANNABIS market: BY product, 2020

FIGURE 15 Europe MEDICAL CANNABIS market: BY product, 2021-2028 (USD Million)

FIGURE 16 Europe MEDICAL CANNABIS market: BY product, CAGR (2021-2028)

FIGURE 17 Europe MEDICAL CANNABIS market: BY product, LIFELINE CURVE

FIGURE 18 Europe MEDICAL CANNABIS market: BY application, 2020

FIGURE 19 Europe MEDICAL CANNABIS market: BY application, 2021-2028 (USD Million)

FIGURE 20 Europe MEDICAL CANNABIS market: BY application, CAGR (2021-2028)

FIGURE 21 Europe MEDICAL CANNABIS market: BY application, LIFELINE CURVE

FIGURE 22 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2020

FIGURE 23 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2021-2028 (USD Million)

FIGURE 24 Europe MEDICAL CANNABIS market: BY DERIVATIVES, CAGR (2021-2028)

FIGURE 25 Europe MEDICAL CANNABIS market: BY DERIVATIVES, LIFELINE CURVE

FIGURE 26 Europe MEDICAL CANNABIS market: BY source, 2020

FIGURE 27 Europe MEDICAL CANNABIS market: BY source, 2021-2028 (USD Million)

FIGURE 28 Europe MEDICAL CANNABIS market: BY source, CAGR (2021-2028)

FIGURE 29 Europe MEDICAL CANNABIS market: BY source, LIFELINE CURVE

FIGURE 30 Europe MEDICAL CANNABIS market: BY species, 2020

FIGURE 31 Europe MEDICAL CANNABIS market: BY species, 2021-2028 (USD Million)

FIGURE 32 Europe MEDICAL CANNABIS market: BY species, CAGR (2021-2028)

FIGURE 33 Europe MEDICAL CANNABIS market: BY species, LIFELINE CURVE

FIGURE 34 Europe MEDICAL CANNABIS market: BY route of administration, 2020

FIGURE 35 Europe MEDICAL CANNABIS market: BY route of administration, 2021-2028 (USD Million)

FIGURE 36 Europe MEDICAL CANNABIS market: BY route of administration, CAGR (2021-2028)

FIGURE 37 Europe MEDICAL CANNABIS market: BY route of administration, LIFELINE CURVE

FIGURE 38 Europe MEDICAL CANNABIS market: BY end user, 2020

FIGURE 39 Europe MEDICAL CANNABIS market: BY end user, 2021-2028 (USD Million)

FIGURE 40 Europe MEDICAL CANNABIS market: BY end user, CAGR (2021-2028)

FIGURE 41 Europe MEDICAL CANNABIS market: BY end user, LIFELINE CURVE

FIGURE 42 Europe MEDICAL CANNABIS market: BY distribution channel, 2020

FIGURE 43 Europe MEDICAL CANNABIS market: BY distribution channel , 2021-2028 (USD Million)

FIGURE 44 Europe MEDICAL CANNABIS market: BY distribution channel , CAGR (2021-2028)

FIGURE 45 Europe MEDICAL CANNABIS market: BY distribution channel, LIFELINE CURVE

FIGURE 46 europe medical cannabis MARKET: SNAPSHOT (2020)

FIGURE 47 europe medical cannabis MARKET: BY COUNTRY (2020)

FIGURE 48 europe medical cannabis MARKET: BY COUNTRY (2021 & 2028)

FIGURE 49 europe medical cannabis MARKET: BY COUNTRY (2020 & 2028)

FIGURE 50 europe medical cannabis MARKET: BY type (2021-2028)

FIGURE 51 Europe Medical Cannabis market: company share 2020 (%)

Detaillierte Informationen anzeigen Right Arrow

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The Medical Cannabis Market size will be worth USD 24,646.06 million by 2031 during the forecast period.
The Medical Cannabis Market growth rate is 33.6% during the forecast period.
The Rise in the Geriatric Population and Rise in Incidence of Diseases that Require the Use of Cannabis are the growth drivers of the Europe Medical Cannabis Market.
The product, source, species, derivatives, application, route of administration, end user, and distribution channel are the factors on which the Europe Medical Cannabis Market research is based.
The major companies in the Europe Medical Cannabis Market are Tilray, Althea Company Pty Ltd (A subsidiary of Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY, and Sanity Group GmbH.

Verwandte Seiten durchsuchen

Banner